EATG » Tuberculosis

Tuberculosis

An Activist’s Guide to Rifapentine

Treatment Action Group (TAG)'s An Activist’s Guide to Rifapentine details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active…

Сall for applications: Regional meeting on capacity building on DR-TB treatment in the EECA region

The TB Europe Coalition (TBEC) announced a call for applications to participate in a regional meeting on capacity building of civil society to advocate for safe and affordable drug-resistant TB…

Ensuring access to life-saving medicines as countries shift from Global Fund support

An editorial published in the Bulletin of the World Health Organization explains the risks related to the quality, affordability and supply of HIV and TB medical commodities with the shift from…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 355 of the ‘Global Fund Observer.’ The newsletter includes a…

International $6 million grant to study HIV/TB coinfection in kids

PITTSBURGH, 1/5/2019 – About a third of us are walking around with the bacteria that causes tuberculosis (TB) in our bodies, but most don’t actually end up with TB. For…

Global Fund launches new Data Explorer to present information on investments worldwide

Global Fund to Fight AIDS, Tuberculosis and Malaria: Global Fund Data Explorer The Global Fund last week launched its new Global Fund Data Explorer. According to the update, “The Data Explorer…

In early pledge, Portugal more than triples its commitment to the Global Fund

PORTO, 29 April 2019 – The Global Fund applauds Portugal’s pledge of €750,000 to the Global Fund’s Sixth Replenishment, which is more than triple its previous commitment. “The Portuguese Ministry…

MSF: Johnson & Johnson should make TB drug available for all at $1/day

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be…

USAID’s TB strategy as seen from Kyrgyzstan

BISHKEK, Kyrgyzstan — When Eremina found out she had multidrug-resistant tuberculosis in 2017 and was headed to hospital, she was convinced she’d never go home. Two of her relatives with…

Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB. On 23 April 2019, TB advocates sent…